Lijuan Qiu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lijuan Qiu has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Ai Wang
Key Laboratory of Chemical Biology and Molecular Engineering of the Education Ministry, Institute of Molecular Science, Shanxi University, Taiyuan 030006, China
1 shared publication - An-Jing Ren
Experimental Teaching Center, College of Basic Medical Sciences, Naval Medical University, Shanghai 200433, China
1 shared publication - Caixia Yuan
Key Laboratory of Chemical Biology and Molecular Engineering, Ministry of Education, Key Laboratory of Materials for Energy Storage and Conversion of Shanxi Province, Institute of Molecular Science, Shanxi University, 92 Wucheng Road, Taiyuan, Shanxi, 030006, People's Republic of China
1 shared publication - Lina Qiu
School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083, China
1 shared publication Liping Lu
Institute of Molecular Science, Key Laboratory of Chemical Biology and Molecular Engineering of the Education Ministry, Shanxi University, Taiyuan 030006, Shanxi, China
1 shared publication- Na Liu
College of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083, China
1 shared publication
Latest Publications
- 23 May 2025
- Published by Wiley in Journal of Peptide Science
- Vol. 31 (7) , e70012
Structural Modification and Antitumor Activity Study of Peptide Codesane: Discovery of Novel Stapled Peptide Antitumor Agents
The discovery of novel candidate molecules that may transform cancer treatment carries significant clinical implications. Codesane (COD), an 18‐amino acid peptide extracted from the wild bee venom of Colletes daviesanus, is categorized as a cationic α‐helical amphipathic antimicrobial peptide. COD, produced via solid‐phase peptide synthesis, displayed significant antitumor activity in vitro. However, its application as a drug is restricted by conformational flexibility, poor serum stability, and low selectivity. This research focused on designing, synthesizing, and evaluating a series of stapled COD derivatives by all‐hydrocarbon stapling strategy. Compared to the original peptide COD, several of these stapled derivatives showed significant enhancements in α‐helicity, serum resistance, antitumor activity, and cell selectivity. Significantly, the stapled derivative COD‐5, which possesses high helicity, good serum stability, and favorable selectivity, shows promising potential for novel antitumor drug development, whereas COD‐3, characterized by high selectivity and good antitumor activity, serves as a preferred candidate for novel breast cancer therapeutic drugs. These findings provide a solid foundation for developing innovative and highly effective antitumor therapies.
- 23 May 2025
- Published by Wiley in Journal of Peptide Science
- Vol. 31 (7) , e70012
Structural Modification and Antitumor Activity Study of Peptide Codesane: Discovery of Novel Stapled Peptide Antitumor Agents
The discovery of novel candidate molecules that may transform cancer treatment carries significant clinical implications. Codesane (COD), an 18‐amino acid peptide extracted from the wild bee venom of Colletes daviesanus, is categorized as a cationic α‐helical amphipathic antimicrobial peptide. COD, produced via solid‐phase peptide synthesis, displayed significant antitumor activity in vitro. However, its application as a drug is restricted by conformational flexibility, poor serum stability, and low selectivity. This research focused on designing, synthesizing, and evaluating a series of stapled COD derivatives by all‐hydrocarbon stapling strategy. Compared to the original peptide COD, several of these stapled derivatives showed significant enhancements in α‐helicity, serum resistance, antitumor activity, and cell selectivity. Significantly, the stapled derivative COD‐5, which possesses high helicity, good serum stability, and favorable selectivity, shows promising potential for novel antitumor drug development, whereas COD‐3, characterized by high selectivity and good antitumor activity, serves as a preferred candidate for novel breast cancer therapeutic drugs. These findings provide a solid foundation for developing innovative and highly effective antitumor therapies.
- Top Cited PapersOpen Access
- 8 May 2025
- Published by Springer Nature in Amino Acids
- Vol. 57 (1) , 1-22
Therapeutic peptides: chemical strategies fortify peptides for enhanced disease treatment efficacy
Therapeutic peptides, as a unique form of medication composed of orderly arranged sequences of amino acids, are valued for their high affinity, specificity, low immunogenicity, and economical production costs. Currently, more than 100 peptides have already secured market approval. Over 150 are actively undergoing clinical trials, while an additional 400–600 are in the preclinical research stage. Despite this, their clinical application is limited by factors such as salt sensitivity, brief residence in the bloodstream, inadequate cellular uptake, and high structural flexibility. By employing suitable chemical methods to modify peptides, it is possible to regulate important physicochemical factors such as charge, hydrophobicity, conformation, amphiphilicity, and sequence that affect the physicochemical properties and biological activity of peptides. This can overcome the inherent deficiencies of peptides, enhance their pharmacokinetic properties and biological activity, and promote continuous progress in the field of research. A diverse array of modified peptides is currently being developed and investigated across numerous therapeutic fields. Drawing on the latest research, this review encapsulates the essential physicochemical factors and significant chemical modification strategies that influence the properties and biological activity of peptides as pharmaceuticals. It also assesses how physicochemical factors affect the application of peptide drugs in disease treatment and the effectiveness of chemical strategies in disease therapy. Concurrently, this review discusses the prospective advancements in therapeutic peptide development, with the goal of offering guidance for designing and optimizing therapeutic peptides and to delve deeper into the therapeutic potential of peptides for disease intervention.
- 8 May 2025
- Published by Springer Nature in Amino Acids
- Vol. 57 (1) , 1-22
Top Cited PapersOpen AccessTherapeutic peptides: chemical strategies fortify peptides for enhanced disease treatment efficacy
Therapeutic peptides, as a unique form of medication composed of orderly arranged sequences of amino acids, are valued for their high affinity, specificity, low immunogenicity, and economical production costs. Currently, more than 100 peptides have already secured market approval. Over 150 are actively undergoing clinical trials, while an additional 400–600 are in the preclinical research stage. Despite this, their clinical application is limited by factors such as salt sensitivity, brief residence in the bloodstream, inadequate cellular uptake, and high structural flexibility. By employing suitable chemical methods to modify peptides, it is possible to regulate important physicochemical factors such as charge, hydrophobicity, conformation, amphiphilicity, and sequence that affect the physicochemical properties and biological activity of peptides. This can overcome the inherent deficiencies of peptides, enhance their pharmacokinetic properties and biological activity, and promote continuous progress in the field of research. A diverse array of modified peptides is currently being developed and investigated across numerous therapeutic fields. Drawing on the latest research, this review encapsulates the essential physicochemical factors and significant chemical modification strategies that influence the properties and biological activity of peptides as pharmaceuticals. It also assesses how physicochemical factors affect the application of peptide drugs in disease treatment and the effectiveness of chemical strategies in disease therapy. Concurrently, this review discusses the prospective advancements in therapeutic peptide development, with the goal of offering guidance for designing and optimizing therapeutic peptides and to delve deeper into the therapeutic potential of peptides for disease intervention.
- Open Access
Carbon Steel Corrosion Induced by Sulfate-Reducing Bacteria: A Review of Electrochemical Mechanisms and Pathways in Biofilms
Microbial metal corrosion has become an important topic in metal research, which is one of the main causes of equipment damage, energy loss, and economic loss. At present, the research on microbial metal corrosion focuses on the characteristics of corrosion products, the environmental conditions affecting corrosion, and the measures and means of corrosion prevention, etc. In contrast, the main microbial taxa involved in metal corrosion, their specific role in the corrosion process, and the electron transfer pathway research are relatively small. This paper summarizes the mechanism of microbial carbon steel corrosion caused by SRB, including the cathodic depolarization theory, acid metabolite corrosion theory, and the biocatalytic cathodic sulfate reduction mechanism. Based on the reversible nature of electron transfer in biofilms and the fact that electrons must pass through the extracellular polymers layer between the solid electrode and the cell, this paper focuses on three types of electrochemical mechanisms and electron transfer modes of extracellular electron transfer occurring in microbial fuel cells, including direct-contact electron transfer, electron transfer by conductive bacterial hair proteins or nanowires, and electron shuttling mediated by the use of soluble electron mediators. Finally, a more complete pathway of electron transfer in microbial carbon steel corrosion due to SRB is presented: an electron goes from the metal anode, through the extracellular polymer layer, the extracellular membrane, the periplasm, and the intracellular membrane, to reach the cytoplasm for sulfate allosteric reduction. This article also focuses on a variety of complex components in the extracellular polymer layer, such as extracellular DNA, quinoline humic acid, iron sulfide (FeSX), Fe3+, etc., which may act as an extracellular electron donor to provide electrons for the SRB intracellular electron transfer chain; the bioinduced mineralization that occurs in the SRB biofilm can inhibit metal corrosion, and it can be used for the development of green corrosion inhibitors. This provides theoretical guidance for the diagnosis, prediction, and prevention of microbial metal corrosion.
Open AccessCarbon Steel Corrosion Induced by Sulfate-Reducing Bacteria: A Review of Electrochemical Mechanisms and Pathways in Biofilms
Microbial metal corrosion has become an important topic in metal research, which is one of the main causes of equipment damage, energy loss, and economic loss. At present, the research on microbial metal corrosion focuses on the characteristics of corrosion products, the environmental conditions affecting corrosion, and the measures and means of corrosion prevention, etc. In contrast, the main microbial taxa involved in metal corrosion, their specific role in the corrosion process, and the electron transfer pathway research are relatively small. This paper summarizes the mechanism of microbial carbon steel corrosion caused by SRB, including the cathodic depolarization theory, acid metabolite corrosion theory, and the biocatalytic cathodic sulfate reduction mechanism. Based on the reversible nature of electron transfer in biofilms and the fact that electrons must pass through the extracellular polymers layer between the solid electrode and the cell, this paper focuses on three types of electrochemical mechanisms and electron transfer modes of extracellular electron transfer occurring in microbial fuel cells, including direct-contact electron transfer, electron transfer by conductive bacterial hair proteins or nanowires, and electron shuttling mediated by the use of soluble electron mediators. Finally, a more complete pathway of electron transfer in microbial carbon steel corrosion due to SRB is presented: an electron goes from the metal anode, through the extracellular polymer layer, the extracellular membrane, the periplasm, and the intracellular membrane, to reach the cytoplasm for sulfate allosteric reduction. This article also focuses on a variety of complex components in the extracellular polymer layer, such as extracellular DNA, quinoline humic acid, iron sulfide (FeSX), Fe3+, etc., which may act as an extracellular electron donor to provide electrons for the SRB intracellular electron transfer chain; the bioinduced mineralization that occurs in the SRB biofilm can inhibit metal corrosion, and it can be used for the development of green corrosion inhibitors. This provides theoretical guidance for the diagnosis, prediction, and prevention of microbial metal corrosion.
- Open Access
- 8 February 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (4) , 3386
Eukaryotic Ribosomal Protein S5 of the 40S Subunit: Structure and Function
The ribosomal protein RPS5 is one of the prime proteins to combine with RNA and belongs to the conserved ribosomal protein family. It plays a substantial role in the process of translation and also has some non-ribosome functions. Despite the enormous studies on the relationship between the structure and function of prokaryotic RPS7, the structure and molecular details of the mechanism of eukaryotic RPS5 remain largely unexplored. This article focuses on the structure of RPS5 and its role in cells and diseases, especially the binding to 18S rRNA. The role of RPS5 in translation initiation and its potential use as targets for liver disease and cancer are discussed.
- 8 February 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (4) , 3386
Open AccessEukaryotic Ribosomal Protein S5 of the 40S Subunit: Structure and Function
The ribosomal protein RPS5 is one of the prime proteins to combine with RNA and belongs to the conserved ribosomal protein family. It plays a substantial role in the process of translation and also has some non-ribosome functions. Despite the enormous studies on the relationship between the structure and function of prokaryotic RPS7, the structure and molecular details of the mechanism of eukaryotic RPS5 remain largely unexplored. This article focuses on the structure of RPS5 and its role in cells and diseases, especially the binding to 18S rRNA. The role of RPS5 in translation initiation and its potential use as targets for liver disease and cancer are discussed.